A novel -adrenoceptor ligand for positron emission tomography: Evaluation in experimental animals

Author： van Waarde A.   Elsinga P.H.   Doze P.   Heldoorn M.   Jaeggi K.A.   Vaalburg W.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.343, Iss.2, 1998-02, pp. : 289-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Positron emission tomography evaluation of sedative properties of antihistamines

By Yanai Kazuhiko   Zhang Dongying   Tashiro Manabu   Yoshikawa Takeo   Naganuma Fumito   Harada Ryuichi   Nakamura Tadaho   Shibuya Katsuhiko   Okamura Nobuyuki  

Expert Opinion on Drug Safety, Vol. 10, Iss. 4, 2011-07 ,pp. : 613-622

Informa Healthcare

Access to resources Recommend Favorite

Positron Emission Tomography in Drug Development and Drug Evaluation.

By  

Current Pharmaceutical Design, Vol. 6, Iss. 16, 2000-11 ,pp. : 1583-1591

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiac Positron Emission Tomography

By  

Heart Drug, Vol. 2, Iss. 3, 2002-07 ,pp. : 117-126

Karger

Access to resources Recommend Favorite

Radiofluorinated Carbohydrates for Positron Emission Tomography

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 8, 2013-04 ,pp. : 944-950

Bentham Science Publishers

Access to resources Recommend Favorite

Topiramate: A Novel Therapeutic Candidate for Diabetes and Aggression? Positron Emission Tomography (PET) Findings

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 16, Iss. 3, 2016-10 ,pp. : 227-230

Bentham Science Publishers

Access to resources Recommend Favorite